Statins as a newly recognized type of immunomodulator.

Kwak, Brenda, Mulhaupt, Flore, Myit, Samir, Mach, François·2000·Nature Medicine

Cited by (1,001)

Items 101–200 of 1,001

  1. Statins and Stroke
    Matthias Endres · 2005 · Journal of Cerebral Blood Flow & Metabolism
  2. The Cellular and Molecular Basis of Translational Immunometabolism
    Giuseppe Danilo Norata, Giuseppina Caligiuri, Triantafyllos Chavakis, Giuseppe Matarese, Mihai Gheorghe Netea, Antonino Nicoletti, Luke A.J. O'Neill, Federica M. Marelli‐Berg · 2015 · Immunity
  3. Ten-Year Follow-Up of a Randomized Trial of Pravastatin in Heart Transplant Patients
    JON A. KOBASHIGAWA, Jaime D. Moriguchi, Hillel Laks, Liane Wener, Antoine Hage, Michèle A. Hamilton, Greg Cogert, Angela Marquez, Maria Espejo Vassilakis, Jignesh K. Patel et al. · 2005 · The Journal of Heart and Lung Transplantation
  4. Treatment With Statins After Induction of Focal Ischemia in Rats Reduces the Extent of Brain Damage
    Luigi Sironi, Mauro Cimino, Uliano Guerrini, Anna Maria Calvio, Barbara Lodetti, Maria Asdente, Walter Balduini, Rodolfo Paoletti, Elena Tremoli · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
  5. Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human Osteoblasts
    Keizo Ohnaka, Seiko Shimoda, Hajime Nawata, Hiroaki Shimokawa, Kozo Kaibuchi, Yukihide Iwamoto, Ryoichi Takayanagi · 2001 · Biochemical and Biophysical Research Communications
  6. Simvastatin Attenuates Smooth Muscle Neointimal Proliferation and Pulmonary Hypertension in Rats
    Toshihiko Nishimura, John L. Faul, Gerald J. Berry, Laszlo T. Vaszar, Daoming Qiu, Ronald G. Pearl, Peter N. Kao · 2002 · American Journal of Respiratory and Critical Care Medicine
  7. Pleiotropic effects of HMG-CoA reductase inhibitors
    Nikos Werner, Georg Nickenig, Ulrich Laufs · 2002 · Basic Research in Cardiology
  8. Statin Use Is Associated with Improved Function and Survival of Lung Allografts
    B. A. Johnson, Aldo T Iacono, Adriana Zeevi, Kenneth R. McCurry, Steven R. Duncan · 2003 · American Journal of Respiratory and Critical Care Medicine
  9. Optimizing bexarotene therapy for cutaneous T-cell lymphoma
    Rakhshandra Talpur, Staci Ward, Narin Apisarnthanarax, Joan Breuer-McHam, Madeleine A. Duvic · 2002 · Journal of the American Academy of Dermatology
  10. Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
    Ostrowski, Stephen M., Wilkinson, Brandy L., Golde, Todd E., Landreth, Gary · 2007 · Journal of Biological Chemistry
  11. Tackling ischaemic heart disease in rheumatoid arthritis
    George D. Kitas · 2003 · British journal of rheumatology
  12. Potential therapeutic role for statins in respiratory disease
    Eleanor J. Hothersall · 2006 · Thorax
  13. Pleiotropic effects of statins: new therapeutic targets in drug design
    Onkar Bedi, Veena Dhawan, P. L. Sharma, Puneet Kumar · 2016 · Naunyn-Schmiedeberg s Archives of Pharmacology
  14. Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages
    Niels R. Veillard, Vincent Braunersreuther, Claire Arnaud, Fabienne Burger, Graziano Pelli, Sabine Steffens, François Mach · 2005 · Atherosclerosis
  15. Inhibition of Hydroxymethylglutaryl-Coenzyme A Reductase Reduces Th1 Development and Promotes Th2 Development
    Rie Hakamada‐Taguchi, Yoshio Uehara, Kagemasa Kuribayashi, Atsushi Numabe, Kanako Saito, Hideyuki Negoro, Toshiro Fujita, Teruhiko Toyo‐oka, Takuma Kato · 2003 · Circulation Research
  16. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts
    Thomas A. Abbruzzese, Joaquim Michael Havens, Michael Belkin, Magruder C. Donaldson, Anthony D. Whittemore, James K. Liao, Michael S. Conte · 2004 · Journal of Vascular Surgery
  17. Transcriptional regulation of antigen presentation
    Peter J. van den Elsen, Tjadine M. Holling, Hedwich F. Kuipers, Nienke van der Stoep · 2003 · Current Opinion in Immunology
  18. Lack of isoprenoid products raises ex vivo interleukin‐1β secretion in hyperimmunoglobulinemia D and periodic fever syndrome
    Joost Frenkel, Ger T. Rijkers, Saskia H. L. Mandey, Sandra W. M. Buurman, Sander M. Houten, Ronald J. A. Wanders, Hans R. Waterham, Wietse Kuis · 2002 · Arthritis & Rheumatism
  19. Normal Human Kidney HLA-DR–Expressing Renal Microvascular Endothelial Cells
    Kimberly A. Muczynski, David M. Ekle, David M. Coder, Susan K. Anderson · 2003 · Journal of the American Society of Nephrology
  20. Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis
    Michele Mendes Barsante, Ester Roffê, C.M. Yokoro, Wagner Luiz Tafuri, Danielle G. Souza, Vanessa Pinho, Maria S. de Abreu Castro, Mauro Martins Teixeira · 2005 · European Journal of Pharmacology
  21. Targeting inflammation to reduce cardiovascular disease risk: A realistic clinical prospect?
    Welsh, Paul, Grassia, Gianluca, Botha, Shani, Sattar, Naveed, Maffia, Pasquale · 2017 · British Journal of Pharmacology
  22. Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications
    Pål Aukrust, Lars Lysgaard Gullestad, Thor Ueland, Jan Kristian Damås, Arne Yndestad · 2005 · Annals of Medicine
  23. Is Hypertension an Inflammatory Process?
    Boos, Christopher, Lip, Gregory · 2006 · Current Pharmaceutical Design
  24. Beyond aspirin—cancer prevention with statins, metformin and bisphosphonates
    Naomi Gronich, Gad Rennert · 2013 · Nature Reviews Clinical Oncology
  25. Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular Cells
    Uwe Schönbeck, Norbert Gerdes, Nerea Varo, Rebecca S. Reynolds, Daniel B. Horton, Udo Bavendiek, LINDA A. ROBBIE, Peter Ganz, Scott Kinlay, Peter Libby · 2002 · Circulation
  26. Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials.
    J. Corvol, A. Bouzamondo, M. Sirol, J. Hulot, P. Sanchez, P. Lechat · 2003 · Archives of Internal Medicine
  27. Statin Therapy in Acute Coronary Syndromes
    Andrei Carvalho Sposito, M. John Chapman · 2002 · Arteriosclerosis Thrombosis and Vascular Biology
  28. Host-Directed Therapeutic Strategies for Tuberculosis
    Afsal Kolloli, Selvakumar Subbian · 2017 · Frontiers in Medicine
  29. Targeting the Immune System in Atherosclerosis
    Tian Xiao Zhao, Ziad Mallat · 2019 · Journal of the American College of Cardiology
  30. Potential Targets of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor for Multiple Sclerosis Therapy
    Narender Nath, Shailendra Giri, Ratna Chakraborty Prasad, Avtar Kaur Singh, Inderjit Singh · 2004 · The Journal of Immunology
  31. Reduced Connexin43 Expression Inhibits Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor–Deficient Mice
    Brenda Renata Kwak, Niels R. Veillard, Graziano Pelli, Flore Mulhaupt, Richard William James, Marc Chanson, François Mach · 2003 · Circulation
  32. A Novel RANTES Antagonist Prevents Progression of Established Atherosclerotic Lesions in Mice
    Vincent Braunersreuther, Sabine Steffens, Claire Arnaud, Graziano Pelli, Fabienne Burger, Amanda E. I. Proudfoot, François Mach · 2008 · Arteriosclerosis Thrombosis and Vascular Biology
  33. Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
    Lars Lysgaard Gullestad, Thor Ueland, JOHN K. KJEKSHUS, Ståle Haugset Nymo, J. Hulthe, Pieter Muntendam, Aram S. Adourian, Michael Böhm, Dirk Jan van Veldhuisen, Michel Komajda N et al. · 2012 · European Heart Journal
  34. High Dose Atorvastatin Decreases Cellular Markers of Immune Activation Without Affecting HIV-1 RNA Levels: Results of a Double-blind Randomized Placebo Controlled Clinical Trial
    Anuradha Ganesan, Nancy F. Crum‐Cianflone, Jeanette M. Higgins, Jing Qin, Catherine A. Rehm, Julia A. Metcalf, Carolyn Brandt, Jean Vita, Catherine F. Decker, Peter A. Sklar et al. · 2011 · The Journal of Infectious Diseases
  35. Simvastatin inhibits T‐cell activation by selectively impairing the function of Ras superfamily GTPases
    Ghittoni, Raffaella, Patrussi, Laura, Pirozzi, Katja, Pellegrini, Michela, Lazzerini, Pietro E., Capecchi, P. Leopoldo, Pasini, Franco Laghi, Baldari, Cosima T. · 2005 · The FASEB Journal
  36. Statins: a viable candidate for host-directed therapy against infectious diseases
    Suraj P. Parihar, Reto Guler, Frank Brombacher · 2018 · Nature reviews. Immunology
  37. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review
    Bernard Noël · 2006 · Journal of the European Academy of Dermatology and Venereology
  38. Experimental and Clinical Basis for the Use of Statins in Patients With Ischemic and Nonischemic Cardiomyopathy
    Kumudha Ramasubbu, Jerry D. Estep, Donna L. White, Anita M Deswal, Douglas L. Mann · 2008 · Journal of the American College of Cardiology
  39. Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy?
    Aryeh M. Abeles, Michael H. Pillinger · 2006 · Arthritis & Rheumatism
  40. Basic Science Review: Statin Therapy-Part I: The Pleiotropic Effects of Statins in Cardiovascular Disease
    Benjamin D. Sadowitz, Kristopher G. Maier, Vivian Gahtan · 2010 · Vascular and Endovascular Surgery
  41. Effects of Interleukin 17 on the cardiovascular system
    Marie Robert, Pierre Miossec · 2017 · Autoimmunity Reviews
  42. Pharmacodynamic activity of drugs and ecotoxicology—can the two be connected?
    J.P. Seiler · 2002 · Toxicology Letters
  43. Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model
    Dardo E. Ferrara, Xiaowei Liu, Ricardo G. Espinola, Pier Luigi Meroni, Imad K. Abukhalaf, E. Nigel Harris, Silvia S. Pierangeli · 2003 · Arthritis & Rheumatism
  44. Statin use is associated with fewer periodontal lesions: A retrospective study
    Otso Lindy, Kimmo Suomalainen, Meeri Mäkelä, Seppo Lindy · 2008 · BMC Oral Health
  45. Statins as potential therapeutic agents in neuroinflammatory disorders
    Olaf Stüve, Sawsan Youssef, Lawrence Steinman, Scott S. Zamvil · 2003 · Current Opinion in Neurology
  46. Immunosuppression in lung transplantation.
    Jenna L. Scheffert, K. Raza · 2014 · PubMed Central
  47. Prevention of stroke and dementia with statins
    Carl J. Vaughan · 2003 · The American Journal of Cardiology
  48. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis
    Romesh Stanislaus, Avtar Kaur Singh, Inderjit Singh · 2001 · Journal of Neuroscience Research
  49. HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis
    Atilla Yılmaz, Christine Reiss, Omeima Tantawi, Alexander Weng, Christian Stumpf, Dorette Raaz, Josef Ludwig, Thomas G. Berger, Alexander Steinkasserer, Werner G. Daniel et al. · 2003 · Atherosclerosis
  50. Statins for Atherosclerosis — As Good as It Gets?
    Michael R. Ehrenstein, Elizabeth C. Jury, Claudia Mauri · 2005 · New England Journal of Medicine
  51. Effects of statins beyond lipid lowering: Potential for clinical benefits
    Khalid Almuti, Rola Rimawi, Daniel M. Spevack, Robert J. Ostfeld · 2005 · International Journal of Cardiology
  52. Fluvastatin inhibits up‐regulation of tissue factor expression by antiphospholipid antibodies on endothelial cells
    Dardo E. Ferrara, Robert A. Swerlick, K. Casper, Pier Luigi Meroni, Mariano E. Vega-Ostertag, E. Nigel Harris, Silvia S. Pierangeli · 2004 · Journal of Thrombosis and Haemostasis
  53. Autoimmune Hepatitis Triggered by Statins
    Vamsee Alla, Joseph P. Abraham, Junaid Siddiqui, Dimple Raina, George Y. Wu, Naga Chalasani, Herbert L. Bonkovsky · 2006 · Journal of Clinical Gastroenterology
  54. Contemporary Concepts in Prevention and Treatment of Cardiac Allograft Vasculopathy
    Mandeep R. Mehra · 2006 · American Journal of Transplantation
  55. Granulomas and Inflammation: Host-Directed Therapies for Tuberculosis
    Hlumani Ndlovu, Mohlopheni Jackson Marakalala · 2016 · Frontiers in Immunology
  56. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
    Flore Mulhaupt · 2003 · Cardiovascular Research
  57. Statin treatment and reduced risk of pneumonia in patients with diabetes
    Ewoudt M.W. van de Garde, Eelko Hak, Patrick Cyriel Souverein, Arno Wilhelmus Hoes, Jules M.M. van den Bosch, Hubert G. M. Leufkens · 2006 · Thorax
  58. Pravastatin Limits Radiation-Induced Vascular Dysfunction in the Skin
    Valérie Holler, Valérie Buard, Marie‐Hélène Gaugler, Olivier Guipaud, Cédric Baudelin, Amandine Saché, María del Rosario Pérez, Claire Squiban, Radia Tamarat, Fabien Milliat et al. · 2009 · Journal of Investigative Dermatology
  59. Local application of statin promotes bone repair through the suppression of osteoclasts and the enhancement of osteoblasts at bone-healing sites in rats
    Yasunori Ayukawa, 安川英輔, Yasuko Moriyama, Yoichiro Ogino, Hiroko Wada, Ikiru Atsuta, Kiyoshi Koyano · 2008 · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology
  60. The pathogenesis and treatment of chronic allograft nephropathy
    Can Li, Chul Woo Yang · 2009 · Nature Reviews Nephrology
  61. Combined Therapy With Simvastatin and Bone Marrow–Derived Mesenchymal Stem Cells Increases Benefits in Infarcted Swine Hearts
    Yue-Jin Yang, Hai‐Yan Qian, Ji Huang, Xiao Hai Li, Run-Lin Gao, Ke-Fei Dou, Guo-Sheng Yang, James T. Willerson, Yong‐Jian Geng · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
  62. Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts
    Yanmin Yang, Hong Qian, Ji Huang, Yong‐Jian Geng, R L Gao, Kefei Dou, Guang-Shun Yang, J.-J. Li, Rui Shen, Zijun He et al. · 2008 · European Heart Journal
  63. Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease
    Rajesh Gupta, Laura Plantinga, Nancy E. Fink, Michal L. Melamed, Josef Coresh, Caroline S. Fox, Nathan W. Levin, Neil R. Powe · 2007 · JAMA
  64. Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial
    An Ho Liem · 2002 · European Heart Journal
  65. Atorvastatin activates PPAR-γ and attenuates the inflammatory response in human monocytes
    O Grip, Sabina M Janciauskiene, Stefan C. Lindgren · 2002 · Inflammation Research
  66. Simvastatin prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced striatal dopamine depletion and protein tyrosine nitration in mice
    Michael L. Selley · 2005 · Brain Research
  67. Differential effects of statins on relevant functions of human monocyte-derived dendritic cells
    Atilla Yılmaz, Christine Reiss, Alexander Weng, Iwona Cicha, Christian Stumpf, Alexander Steinkasserer, Werner G. Daniel, Christoph D. Garlichs · 2005 · Journal of Leukocyte Biology
  68. Toward Immunomodulatory and Anti-Inflammatory Properties of Statins
    Claire Arnaud, Vincent Braunersreuther, François Mach · 2005 · Trends in Cardiovascular Medicine
  69. Oral High-Dose Atorvastatin Treatment in Relapsing-Remitting Multiple Sclerosis
    Friedemann Paul, Sonia Waiczies, Jens Thomas Wuerfel, Judith Bellmann–Strobl, Jan R. Dörr, Helmar Waiczies, Mareile Haertle, Klaus Dieter Wernecke, Hans‐Dieter Volk, Orhan Aktaş et al. · 2008 · PLoS ONE
  70. Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial
    Gilda Aparecida Ferreira, Túlio Pinho Navarro, Rosa Weiss Telles, Luís Eduardo Coelho Andrade, Emília Inoue Sato · 2007 · Lara D. Veeken
  71. A Multicenter, Randomized, Placebo‐Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis
    George D. Kitas, Peter Nightingale, Jane Armitage, Naveed A. Sattar, J. J. F. Belch, Deborah P. M. Symmons · 2019 · Arthritis & Rheumatology
  72. Inflammation and coronary artery disease
    Alice Y. Tiong, David B. Brieger · 2005 · American Heart Journal
  73. Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation
    Jumei Shi, Junru Wang, Huaien Zheng, Wen Ling, Jacob Joseph, Dayuan Li, Jawahar L. Mehta, Usha Ponnappan, Pei Lin, Louis M. Fink et al. · 2003 · Blood Coagulation & Fibrinolysis
  74. Therapy with statins in patients with refractory rheumatic diseases: a preliminary study
    Carlos Abud‐Mendoza, Hortensia de la Fuente, Enrique Cuevas-Orta, Lourdes Baranda, J Cruz-Rizo, Roberto González‐Amaro · 2003 · Lupus
  75. Mesenchymal stem cells and cardiac repair
    Catharina Neßelmann, Nan Ma, Karen Bieback, Wolfgang Wagner, Anthony Dick Ho, Yrjö Tapio Konttinen, Hao Zhang, Mihail Eugen Hinescu, Gustav Steinhoff · 2008 · Journal of Cellular and Molecular Medicine
  76. Transcriptional analysis of targets in multiple sclerosis
    L. Steinman, S. Zamvil · 2003 · Nature reviews. Immunology
  77. Gamma interferon: a central mediator in atherosclerosis
    Martha Leticia Alfaro León, Steven H. Zuckerman · 2005 · Inflammation Research
  78. Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches
    Lars Lysgaard Gullestad, Pål Aukrust · 2005 · The American Journal of Cardiology
  79. Simvastatin Decreases Nitric Oxide Overproduction and Reverts the Impaired Vascular Responsiveness Induced by Endotoxic Shock in Rats
    Alexandre Giusti‐Paiva, Maria Regina Martinez, Jorge Vinícius Cestari Félix, Maria José Alves Rocha, Evelin Capellari Cárnio, Lucila Leico Kagohara Elias, José Antunes‐Rodrigues · 2004 · Shock
  80. Simvastatin Treatment of Pulmonary Hypertension*
    Peter N. Kao · 2005 · CHEST Journal
  81. Simvastatin as add-on therapy to interferon beta-1a for relapsing-remitting multiple sclerosis (SIMCOMBIN study): a placebo-controlled randomised phase 4 trial
    Per Soelberg Sørensen, Jan Lycke, Juha-Pekka Erälinna, Astrid Edland, Xingchen Wu, Jette Lautrup Frederiksen, Annette Bang Oturai, Clas Malmeström, Egon Stenager, Finn Thorup Sellebjerg et al. · 2011 · The Lancet Neurology
  82. Simvastatin Induces the Odontogenic Differentiation of Human Dental Pulp Stem Cells In Vitro and In Vivo
    Yosuke Okamoto, Wataru Sonoyama, Mitsuaki Ono, Kentaro Akiyama, Takuo Fujisawa, Masamitsu Oshima, Yohei Tsuchimoto, Yoshizo Matsuka, Tatsuji Yasuda, Songtao Shi et al. · 2009 · Journal of Endodontics
  83. Statins and their role in vascular protection
    Justin Charles Mason · 2003 · Clinical Science
  84. Statins: panacea for sepsis?
    Marius Terblanche, Yaniv Almog, Robert S. Rosenson, Terry S. Smith, Daniel G. Hackam · 2006 · The Lancet Infectious Diseases
  85. Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice
    Sarah H. A. Lawman, Claudia Mauri, Elizabeth C. Jury, H. Terrence Cook, Michael R. Ehrenstein · 2004 · The Journal of Immunology
  86. Statin reduces mortality and morbidity in systemic lupus erythematosus patients with hyperlipidemia: A nationwide population-based cohort study
    Hsin‐Hui Yu, Pau‐Chung Chen, Yao‐Hsu Yang, Li‐Chieh Wang, Jyh‐Hong Lee, Yu‐Tsan Lin, Bor‐Luen Chiang · 2015 · Atherosclerosis
  87. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma
    Daniel Menzies, Arun Nair, Karen T. Meldrum, Dawn Fleming, Martyn Lawrence Barnes, Brian Jonathon Lipworth · 2006 · Journal of Allergy and Clinical Immunology
  88. Pitavastatin-Induced Thrombomodulin Expression by Endothelial Cells Acts Via Inhibition of Small G Proteins of the Rho Family
    Katsuhiko Masamura, Koji Oida, Hideo Kanehara, Jinya Suzuki, Shuichi Horie, Hidemi Ishii, Isamu Miyamori · 2003 · Arteriosclerosis Thrombosis and Vascular Biology
  89. Neuroinflammation: a potential therapeutic target
    Craft, Jeffrey M, Watterson, D Martin, Van Eldik, Linda J · 2005 · Expert Opinion on Therapeutic Targets
  90. Identifying the anti-inflammatory response to lipid lowering therapy: a position paper from the working group on atherosclerosis and vascular biology of the European Society of Cardiology
    José Tuñón, Lina Badimón, Marie‐Luce Bochaton‐Piallat, Bertrand Cariou, Mat J.A.P. Daemen, Jesús Egido, Paul Charles Evans, Imo E. Hoefer, Daniel F.J. Ketelhuth, Esther Lutgens et al. · 2018 · Cardiovascular Research
  91. Statin adjunctive therapy shortens the duration of TB treatment in mice
    Noton Kumar Dutta, Natalie Bruiners, Michael L. Pinn, Matthew D. Zimmerman, Brendan Prideaux, Veronique Anne Dartois, Maria Laura Gennaro, Petros C. Karakousis · 2016 · Journal of Antimicrobial Chemotherapy
  92. Metabolic syndrome: the danger signal in atherosclerosis
    Patrick Mathieu, Philippe Pîbarot, Jean‐Pierre Després · 2006 · Vascular Health and Risk Management
  93. Statins as Immunomodulatory Agents
    François Mach · 2004 · Circulation
  94. Simvastatin promotes Th2-type responses through the induction of the chitinase family member Ym1 in dendritic cells
    Meenakshi Arora, Li Chen, Melissa Paglia, Iain J. Gallagher, Judith E. Allen, Yatin M. Vyas, Anuradha Ray, Prabir Ray · 2006 · Proceedings of the National Academy of Sciences
  95. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival
    Mandeep R. Mehra, Patricia A. Uber, Krishnamoorthy Vivekananthan, Sergio Solis, Robert L. Scott, Myung Park, Richard V. Milani, Carl J. Lavie · 2002 · Journal of the American College of Cardiology
  96. Selenoproteins, Cholesterol-Lowering Drugs, and the Consequences Revisiting of the Mevalonate Pathway
    Bernd Moosmann, Christian Behl · 2004 · Trends in Cardiovascular Medicine
  97. HDL and ApoA-I inhibit antigen presentation-mediated T cell activation by disrupting lipid rafts in antigen presenting cells
    Wang, Shu-hui, Yuan, Shu-guang, Peng, Dao-quan, Zhao, Shui-ping · 2012 · Atherosclerosis
  98. Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in Hyper-IgD and periodic fever syndrome
    Sander M. Houten · 2002 · Human Molecular Genetics
  99. Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy
    Anne Grete Semb, Sanne van Wissen, Thor Ueland, Tineke Jacoba Smilde, Torgun Wæhre, Mieke D. Trip, Stig Sophus Frøland, John J.P. Kastelein, Lars Lysgaard Gullestad, Terje Rolf Pedersen et al. · 2003 · Journal of the American College of Cardiology
  100. Effect of fluvastatin on acute renal allograft rejection: A randomized multicenter trial
    Hallvard Holdaas, Alan G. Jardine, David Collins. Wheeler, Inge Bjørn Brekke, Peter J. Conlon, Bengt Fellström, Abdel Hammad, Ingar Holme, Helena Isoniemi, Richard H. Moore et al. · 2001 · Kidney International